Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus
Endocrine, Metabolic and Immune Disorders - Drug Targets - United Arab Emirates
doi 10.2174/187153009787582388
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2009
Authors
Publisher
Bentham Science Publishers Ltd.